PUBLIC RESEARCH DOSSIER
CLYM · NasdaqClimb Bio, Inc.
Manufacturing · Pharmaceutical Preparations完成交易日收盘US$9.75+0.1%行情日期 2026-11-03 · 非实时
公开资料页汇总Climb Bio, Inc.（CLYM）的已发布行情、估值、风险、财务摘要与同业对比。行情截至2026-11-03，非实时；缺失值不按零处理。
股价走势
复权收盘价（美元）
2025-10-31 — 2026-11-03253 个交易日样本
CLYMUS$9.75
查看图表数据
| 日期 | CLYM |
|---|---|
| 2025-10-31 | 2.05 |
| 2025-11-03 | 2 |
| 2025-11-04 | 1.88 |
| 2025-11-05 | 1.92 |
| 2025-11-06 | 1.95 |
| 2025-11-07 | 1.83 |
| 2025-11-10 | 1.8 |
| 2025-11-11 | 1.9 |
| 2025-11-12 | 1.92 |
| 2025-11-13 | 1.87 |
| 2025-11-14 | 1.9 |
| 2025-11-17 | 1.88 |
| 2025-11-18 | 1.91 |
| 2025-11-19 | 1.84 |
| 2025-11-20 | 1.73 |
| 2025-11-21 | 1.7 |
| 2025-11-24 | 1.76 |
| 2025-11-25 | 1.8 |
| 2025-11-26 | 1.84 |
| 2025-11-28 | 1.89 |
| 2025-12-01 | 1.79 |
| 2025-12-02 | 1.64 |
| 2025-12-03 | 1.74 |
| 2025-12-04 | 1.73 |
| 2025-12-05 | 1.72 |
| 2025-12-08 | 1.81 |
| 2025-12-09 | 1.9 |
| 2025-12-10 | 2.08 |
| 2025-12-11 | 2.3 |
| 2025-12-12 | 3 |
| 2025-12-15 | 3.81 |
| 2025-12-16 | 4.62 |
| 2025-12-17 | 4.25 |
| 2025-12-18 | 4.38 |
| 2025-12-19 | 4.28 |
| 2025-12-22 | 4.9 |
| 2025-12-23 | 4.6 |
| 2025-12-24 | 4.85 |
| 2025-12-26 | 4.93 |
| 2025-12-29 | 4.44 |
| 2025-12-30 | 4.03 |
| 2025-12-31 | 4 |
| 2026-01-02 | 3.75 |
| 2026-01-05 | 3.54 |
| 2026-01-06 | 3.81 |
| 2026-01-07 | 4.2 |
| 2026-01-08 | 4.58 |
| 2026-01-09 | 5.03 |
| 2026-01-12 | 4.7 |
| 2026-01-13 | 4.13 |
| 2026-01-14 | 3.96 |
| 2026-01-15 | 3.77 |
| 2026-01-16 | 4.22 |
| 2026-01-20 | 4.32 |
| 2026-01-21 | 4.29 |
| 2026-01-22 | 4.91 |
| 2026-01-23 | 5.02 |
| 2026-01-26 | 4.77 |
| 2026-01-27 | 5.12 |
| 2026-01-28 | 5.16 |
| 2026-01-29 | 4.78 |
| 2026-01-30 | 4.47 |
| 2026-02-02 | 4.73 |
| 2026-02-03 | 5.15 |
| 2026-02-04 | 5.05 |
| 2026-02-05 | 4.65 |
| 2026-02-06 | 5.44 |
| 2026-02-09 | 5.77 |
| 2026-02-10 | 5.5 |
| 2026-02-11 | 5.56 |
| 2026-02-12 | 5.27 |
| 2026-02-13 | 5.67 |
| 2026-02-17 | 5.61 |
| 2026-02-18 | 5.5 |
| 2026-02-19 | 5.64 |
| 2026-02-20 | 5.63 |
| 2026-02-23 | 5.83 |
| 2026-02-24 | 6.36 |
| 2026-02-25 | 7.09 |
| 2026-02-26 | 7.38 |
| 2026-02-27 | 7.15 |
| 2026-03-02 | 7.07 |
| 2026-03-03 | 7.09 |
| 2026-03-04 | 7.28 |
| 2026-03-05 | 7.39 |
| 2026-03-06 | 7.18 |
| 2026-03-09 | 7.25 |
| 2026-03-10 | 7.33 |
| 2026-03-11 | 7.33 |
| 2026-03-12 | 7.26 |
| 2026-03-13 | 7.03 |
| 2026-03-16 | 7.13 |
| 2026-03-17 | 7.12 |
| 2026-03-18 | 7.12 |
| 2026-03-19 | 6.98 |
| 2026-03-20 | 6.11 |
| 2026-03-23 | 6.54 |
| 2026-03-24 | 6.68 |
| 2026-03-25 | 6.98 |
| 2026-03-26 | 7.11 |
| 2026-03-27 | 7.02 |
| 2026-03-30 | 6.54 |
| 2026-03-31 | 6.85 |
| 2026-04-01 | 6.95 |
| 2026-04-02 | 6.56 |
| 2026-04-06 | 6.74 |
| 2026-04-07 | 6.87 |
| 2026-04-08 | 7.1 |
| 2026-04-09 | 8.05 |
| 2026-04-10 | 8.41 |
| 2026-04-13 | 8.63 |
| 2026-04-14 | 8.85 |
| 2026-04-15 | 8.65 |
| 2026-04-16 | 8.82 |
| 2026-04-17 | 9.16 |
| 2026-04-20 | 8.97 |
| 2026-04-21 | 9.37 |
| 2026-04-22 | 9.3 |
| 2026-04-23 | 9.02 |
| 2026-04-24 | 9.14 |
| 2026-04-27 | 9.5 |
| 2026-04-28 | 9.26 |
| 2026-04-29 | 8.78 |
| 2026-04-30 | 8.88 |
| 2026-05-01 | 8.91 |
| 2026-05-04 | 9.69 |
| 2026-05-05 | 11.45 |
| 2026-05-06 | 12.22 |
| 2026-05-07 | 11.91 |
| 2026-05-08 | 11.37 |
| 2026-05-11 | 11.12 |
| 2026-05-12 | 11.17 |
| 2026-05-13 | 11.41 |
| 2026-05-14 | 11.33 |
| 2026-05-15 | 10.8 |
| 2026-05-18 | 9.88 |
| 2026-05-19 | 9.65 |
| 2026-05-20 | 10.52 |
| 2026-05-21 | 10.91 |
| 2026-05-22 | 11 |
| 2026-05-26 | 11.39 |
| 2026-05-27 | 11.96 |
| 2026-05-28 | 11.34 |
| 2026-05-29 | 10.96 |
| 2026-06-01 | 11.8 |
| 2026-06-02 | 11.2 |
| 2026-06-03 | 10.44 |
| 2026-06-04 | 10.91 |
| 2026-06-05 | 10.55 |
| 2026-06-08 | 10.77 |
| 2026-06-09 | 11.14 |
| 2026-06-10 | 10.8 |
| 2026-06-11 | 10.91 |
| 2026-06-12 | 11.44 |
| 2026-06-15 | 11.49 |
| 2026-06-16 | 10.71 |
| 2026-06-17 | 11.34 |
| 2026-06-18 | 11.45 |
| 2026-06-22 | 12.18 |
| 2026-06-23 | 12.3 |
| 2026-06-24 | 12.75 |
| 2026-06-25 | 12.66 |
| 2026-06-26 | 13.08 |
| 2026-06-29 | 13.36 |
| 2026-06-30 | 13.04 |
| 2026-07-01 | 13.29 |
| 2026-07-02 | 12.9 |
| 2026-07-06 | 13.27 |
| 2026-07-07 | 13.42 |
| 2026-07-08 | 13.57 |
| 2026-07-09 | 13.82 |
| 2026-07-10 | 14 |
| 2026-07-13 | 13.21 |
| 2026-07-14 | 13.24 |
| 2026-07-15 | 13.87 |
| 2026-07-16 | 12.58 |
| 2026-07-17 | 12.7 |
| 2026-07-20 | 12.22 |
| 2026-07-21 | 13.1 |
| 2026-07-22 | 12.58 |
| 2026-07-23 | 12.76 |
| 2026-07-24 | 12.84 |
| 2026-07-27 | 12.79 |
| 2026-07-28 | 12.29 |
| 2026-07-29 | 12.11 |
| 2026-07-30 | 12.08 |
| 2026-07-31 | 11.9 |
| 2026-08-03 | 11.81 |
| 2026-08-04 | 12.56 |
| 2026-08-05 | 12.47 |
| 2026-08-06 | 14 |
| 2026-08-07 | 14 |
| 2026-08-10 | 13.54 |
| 2026-08-11 | 13.85 |
| 2026-08-12 | 14.39 |
| 2026-08-13 | 14.73 |
| 2026-08-14 | 16.33 |
| 2026-08-17 | 17.44 |
| 2026-08-18 | 17.39 |
| 2026-08-19 | 17.34 |
| 2026-08-20 | 17.02 |
| 2026-08-21 | 17.28 |
| 2026-08-24 | 16.4 |
| 2026-08-25 | 17.84 |
| 2026-08-26 | 16.08 |
| 2026-08-27 | 15.06 |
| 2026-08-28 | 14.57 |
| 2026-08-31 | 13.73 |
| 2026-09-01 | 14.82 |
| 2026-09-02 | 15.05 |
| 2026-09-03 | 14.59 |
| 2026-09-04 | 15.52 |
| 2026-09-08 | 15.9 |
| 2026-09-09 | 15.05 |
| 2026-09-10 | 14.95 |
| 2026-09-11 | 14.25 |
| 2026-09-14 | 14.56 |
| 2026-09-15 | 13.91 |
| 2026-09-16 | 14.11 |
| 2026-09-17 | 14.06 |
| 2026-09-18 | 14.05 |
| 2026-09-21 | 13.64 |
| 2026-09-22 | 14.21 |
| 2026-09-23 | 12.52 |
| 2026-09-24 | 11.89 |
| 2026-09-25 | 11.66 |
| 2026-09-28 | 11.74 |
| 2026-09-29 | 11.5 |
| 2026-09-30 | 11.47 |
| 2026-10-01 | 11.07 |
| 2026-10-02 | 10.94 |
| 2026-10-05 | 11.05 |
| 2026-10-06 | 10.68 |
| 2026-10-07 | 10.71 |
| 2026-10-08 | 10.86 |
| 2026-10-09 | 11 |
| 2026-10-12 | 10.83 |
| 2026-10-13 | 10.31 |
| 2026-10-14 | 10.29 |
| 2026-10-15 | 10.91 |
| 2026-10-16 | 9.82 |
| 2026-10-19 | 9.73 |
| 2026-10-20 | 10.8 |
| 2026-10-21 | 10.87 |
| 2026-10-22 | 10.54 |
| 2026-10-23 | 10.19 |
| 2026-10-26 | 8.81 |
| 2026-10-27 | 9.57 |
| 2026-10-28 | 10.12 |
| 2026-10-29 | 10.33 |
| 2026-10-30 | 10.25 |
| 2026-11-02 | 9.74 |
| 2026-11-03 | 9.75 |
1、3、6、12个月分别按21、63、126、252个交易日取区间；缺失日期不从区间外补齐。
使用已有每日复权收盘样本，非实时行情；图中价格可能与未复权收盘报价不同。
01 · MARKET FRAME
行情、估值与风险
基于已完成交易日和已发布财务资料
区间涨跌幅
区间涨跌幅使用复权收盘价；估值和风险指标缺失时显示为—，不按零处理。
02 · FINANCIAL TRACE
财务摘要
公开页仅显示最近3个已校验报告期
年度财务走势
百万美元 · 年度报告期
所选指标暂无已校验的年度资料，缺失值不按零处理。
| 指标 | 2026-07-31 | 2026-06-30 | 2025-12-31 | 2025-07-31 | 2025-06-30 | 2024-12-31 | 2024-08-12 | 2024-06-30 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| 营收 | — | — | — | — | — | — | — | — | — |
| 净利润 | — | — | -59.9 | — | — | -73.9 | — | — | -35.1 |
| 自由现金流 | — | — | -54.5 | — | — | -15.6 | — | — | — |
| 股份数 | 57.4 | — | — | 67.8 | — | — | 67.1 | — | — |
| 债务 | — | — | — | — | — | — | — | — | — |
| 总资产 | — | 246.3 | — | — | 192.4 | — | — | 226 | — |
金额及股份数均以百万为单位。缺失或待核验数据不按零处理。
03 · PEER SET
同业对比
同一细分行业中市值最接近的公司
| 公司 | 市值 | 近250日涨跌幅 | 市盈率 | 距52周高点 | 波动率 |
|---|---|---|---|---|---|
| ACRSAclaris Therapeutics, Inc. | US$550.5M | +58.5% | — | — | — |
| BCAXBicara Therapeutics Inc. | US$592.9M | -39.2% | — | — | — |
| ABUS阿布图斯生物制药 | US$594.7M | -13.8% | — | — | — |
| ANLAdlai Nortye Group Ltd. | US$616.9M | +609.6% | — | — | — |
同业由已覆盖公司的行业分类和市值接近度确定，仅用于横向研究；缺失数据不按零处理。